The adenomatous polyposis coli (APC) tumour suppressor - genetics, function and disease

Citation
Om. Sieber et al., The adenomatous polyposis coli (APC) tumour suppressor - genetics, function and disease, MOL MED TOD, 6(12), 2000, pp. 462-469
Citations number
83
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
MOLECULAR MEDICINE TODAY
ISSN journal
13574310 → ACNP
Volume
6
Issue
12
Year of publication
2000
Pages
462 - 469
Database
ISI
SICI code
1357-4310(200012)6:12<462:TAPC(T>2.0.ZU;2-6
Abstract
Mutations in the adenomatous polyposis coli (APC) gene are the basis of fam ilial adenomatous polyposis and the majority of sporadic colorectal cancer. APC is expressed in a wide variety of tissues, interacts with the cytoskel eton, is involved in regulating levels of beta -catenin and, most recently, has been shown to bind DNA, suggesting that it may possess a nuclear role. The mutation spectrum implicated in tumorigenesis and its correlation with disease phenotype is well characterized and has contributed to our underst anding of important functional domains in APC, Despite these advances, APC continues to provide a fertile subject of research for both colorectal tumo rigenesis and cancer in general.